Oncopeptides AB Strategic Asset Allocation Index
Oncopeptides AB strategic asset allocation index. Oncopeptides AB (ONCO) has a Strategic Asset Allocation Index of 304.6% as of September 2025. Strategic assets (PP&E of Skr19.91 Million plus long-term investments of Skr-) total Skr19.91 Million, measured against net assets of Skr6.54 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Oncopeptides AB balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Oncopeptides AB (2014–2024)
Strategic asset allocation index of Oncopeptides AB from 2014 to 2024. This chart shows how Oncopeptides AB's Strategic Asset Allocation Index has evolved across 10 annual periods from 2014 to 2024. As of September 2025, the index stands at 304.6%, representing strategic assets of Skr19.91 Million against net assets of Skr6.54 Million SEK. Check ONCO intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Oncopeptides AB Strategic Asset Allocation Index by Year (2014–2024)
Oncopeptides AB strategic asset allocation index by year from 2014 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Oncopeptides AB from 2014 to 2024, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Oncopeptides AB.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 49.9% | Skr27.11 Million | Skr27.11 Million | Skr- | Skr54.28 Million | ▼ -11.0 pp |
| 2023 | 61.0% | Skr34.63 Million | Skr34.63 Million | Skr- | Skr56.78 Million | ▲ +54.0 pp |
| 2022 | 6.9% | Skr20.44 Million | Skr20.44 Million | Skr- | Skr294.29 Million | ▼ -4.8 pp |
| 2021 | 11.7% | Skr24.74 Million | Skr24.74 Million | Skr- | Skr210.87 Million | ▲ +5.1 pp |
| 2020 | 6.6% | Skr38.33 Million | Skr38.33 Million | Skr- | Skr576.90 Million | ▲ +4.1 pp |
| 2019 | 2.6% | Skr20.49 Million | Skr17.19 Million | Skr3.30 Million | Skr797.01 Million | ▲ +1.8 pp |
| 2018 | 0.7% | Skr2.36 Million | Skr2.36 Million | Skr- | Skr315.83 Million | ▲ +0.1 pp |
| 2017 | 0.6% | Skr2.60 Million | Skr2.34 Million | Skr263.00K | Skr418.00 Million | ▼ -3.6 pp |
| 2016 | 4.2% | Skr1.10 Million | Skr1.10 Million | Skr- | Skr26.34 Million | ▲ +4.0 pp |
| 2014 | 0.2% | Skr15.00K | Skr15.00K | Skr- | Skr7.61 Million | — |